15
total announcements
538837.BO · 15 min delayed
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has complied with Regulation 74(5) of SEBI (DP) Regulations, 2018 by furnishing details of securities dematerialized during the quarter ended September 30, 2026 to all stock exchanges where the company's shares are listed.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has announced that the US FDA inspection of its Bioanalytical Facility in Hyderabad has been successfully closed with no observations, and the Establishment Inspection Report (EIR) has been released on 30 September 2026.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has announced the closure of its trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015, from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter ended September 30, 2026.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has disclosed the voting results of its 28th Annual General Meeting (AGM) held on September 25, 2026, through video conference. All resolutions were approved by the members with requisite majority.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd held its 28th Annual General Meeting on 25-09-2026, which was conducted through video conferencing. The meeting was attended by 82 members, and the resolutions related to the standalone and consolidated audited balance sheet, appointment of directors, and other business were passed.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has published a newspaper advertisement disclosing notice and e-voting information for its 28th Annual General Meeting.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd submitted its 28th Annual Report for FY 2025-26 under Regulation 34 of SEBI (LODR) Regulations, 2015. The report is available on the company's website and will be presented at the Annual General Meeting on September 25, 2026.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has submitted its 28th Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR) Regulation 2015, and has scheduled its Annual General Meeting for 25.09.2026.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has submitted a statement to the BSE, stating that there are no deviations or variations in the utilization of funds raised through a preferential allotment during the quarter ended June 30, 2026.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has announced changes in its board of directors, including the re-appointment of Mrs. Snigdha Mothukuri as Whole Time Director for 3 years, continuation of Mr. Nageswar Rao Yarllagadda as Whole Time Director beyond the age of 70, and re-appointment of Mr. Suryaprakasa Rao Bommisetti as Independent Director for 5 years. The company has also announced the appointment of Mr. Kolli Srinivas Rao as additional & Independent Director for 5 years and the re-appointment of Mrs. Snigdha Mothukuri and Mr. Krishna Kishore Kuchipudi as Directors of the company, retire by rotation.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has announced unaudited financial results for the quarter ended 30.06.2026, along with the re-appointment of directors and other board decisions.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd's board meeting outcome includes the approval of un-audited financial results for the quarter ended 30.06.2026, re-appointment of directors, and notice of the annual general meeting.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider unaudited financial results for the quarter ended 30.06.2026, limited review report, and other related matters.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd has received approval from CDSCO to increase the bed capacity of its existing Bioavailability/Bioequivalence Study Centre from 132 and 06 ICU beds to 156 and 08 ICU beds.
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd (JSTL) has announced the successful completion of a USFDA inspection at its Bioanalytical Facility in Hyderabad. The inspection, conducted from July 20-24, 2026, resulted in zero observations, indicating compliance with international regulatory requirements and good practices.